ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets – Medical Marijuana Program Connection

SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, is pleased to announce that Tim Miller is joining the Company as Director of Investor Relations and Capital Markets, effective November 1, 2023. Mr. Miller will be based out of the Company’s Toronto office and brings a wealth of know

Source link

• SEO Powered Content & PR Distribution. Get Amplified Today.
• PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
• PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
• PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
• PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
• Source: https://mmpconnect.com/zyus-life-sciences-corporation-announces-new-director-of-investor-relations-and-capital-markets/?utm_source=rss&utm_medium=rss&utm_campaign=zyus-life-sciences-corporation-announces-new-director-of-investor-relations-and-capital-markets